Objective: This study used meta-analysis to assess disparities in cardiovascular disease
(CVD) screening and treatment in people with mental disorders, a group that has elevated …

Weight gain and metabolic disturbances are frequent in people treated with second
generation antipsychotics (SGA). We aimed to investigate the effect of SGAs on eating …

Background Cardiometabolic dysfunction is common in young people with psychosis.
Recently, the Psychosis Metabolic Risk Calculator (PsyMetRiC) was developed and …

The present cross-sectional, retrospective study aimed to assess the prevalence of
cardiovascular disease (CVD) risk factors and metabolic syndrome in a sample of …

Background International guidelines recommend that individuals with treatment-resistant
psychosis must be treated with clozapine. ECT has also been reported to improve symptom …

Introduction: Pregnant women and fetuses are more likely than ever to be exposed to
antipsychotic drugs (APs) during pregnancy and postpartum period. Second-generation APs …

Introduction The RISKMet project aims to:(1) identify risk factors for metabolic syndrome
(MetS) by comparing patients with and without MetS;(2) characterise patients treated with …

People with severe mental illness (SMI) have numerous risk factors that may predispose
them to food insecurity (FI); however, the prevalence of FI and its effects on health are under …

Objective To describe (i) the clinical characteristics of individuals referred to the Tertiary
Referral Service for Psychosis (TRSP) and (ii) the recommendations TRSP made for future …

The microbiome has been implicated in the development of metabolic conditions which
occur at high rates in people with schizophrenia and related psychoses. This exploratory …